Achieve Life Sciences ACHV
NASDAQ ACHV
$7.53 -0.56 (-6.92%)
At close: Oct 1, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Non Operating Interest Expenses (2022 - 2026)

Updated

Achieve Life Sciences (ACHV) posted Non Operating Interest Expenses of $277,000 for Q2 2026, up 45.0% from $191,000 a year earlier and up 1.1% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Achieve Life Sciences was $994,000, up 5.9% year-over-year; for FY2025, it came in at $819,000, down 62.4% from FY2024.

  • Annual Non Operating Interest Expenses shows a three-year compound annual growth rate of -22.9% (FY2022 to FY2025).
  • In prior years, Achieve Life Sciences' Non Operating Interest Expenses was $2.18 million in FY2024 (-23.6%), $2.85 million in FY2023 (+59.5%) and $1.79 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Non Operating Interest Expenses since Q3 2024.
  • On a year-over-year basis, Non Operating Interest Expenses has increased in each of the last three quarters, with an average decline of 26.1% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q2 2023, with growth of 76.2%; the weakest was Q1 2025, with a decline of 77.2%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $274,000 (Q1 2026), $251,000 (Q4 2025) and $192,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Achieve Life Sciences 352.68 Mn 352.68 Mn - 277,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 277,000.00
Mar 31, 2026 274,000.00
Dec 31, 2025 251,000.00
Sep 30, 2025 192,000.00
Jun 30, 2025 191,000.00
Mar 31, 2025 185,000.00
Dec 31, 2024 197,000.00
Sep 30, 2024 366,000.00
Jun 30, 2024 804,000.00
Mar 31, 2024 813,000.00
Dec 31, 2023 787,000.00
Sep 30, 2023 781,000.00
Jun 30, 2023 712,000.00
Mar 31, 2023 573,000.00
Dec 31, 2022 547,000.00
Sep 30, 2022 481,000.00
Jun 30, 2022 404,000.00
Mar 31, 2022 357,000.00
API Access

Achieve Life Sciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ACHV&period=max&api_key=YOUR_API_KEY